Phenotyping coding variants in cancer using Perturb-seq
Oana Ursu
Regev Lab, Genentech
Presentation Date: 1 February 2022
Oana is a postdoc working with Prof. Aviv Regev at Genentech. She studies the molecular basis of cellular decisions and resulting cell states using pooled high-content screening, applied to profile the impact of coding variation in cancer (collaboration with JT Neal, Jesse Boehm at the Broad Institute).
Social: @oana__ursu